Archer Materials (ASX:AXE)
ASX announcement history & article coverage
Transparent by design.
Announcments by Archer Materials (ASX:AXE) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Change of registry address notification
Notice of Annual General Meeting/Proxy Form
Notification regarding unquoted securities - AXE
Archer CEO to Present at Upcoming Conferences
Notification regarding unquoted securities - AXE
Notice Required Under ASX Listing Rule 3.13.1
Archer launches Quantum Commercial Pilot
Notice under section 708A of the Corporations Act
Change of Director's Interest Notice - GE BH
Application for quotation of securities - AXE
Notification regarding unquoted securities - AXE
Prospectus
2026 Corporate Governance Statement and Appendix 4G
Appendix 4E and 2026 Annual Report
Archer Materials reports FY26 net loss of $6.36 million, advances quantum and biochip tech, and signs strategic IonQ agreement
Results of General Meeting
Early Pre-Pilot Study Advances Potassium Biosensor
Archer advances potassium Biosensor development with promising blood collection study results
Application for quotation of securities - AXE
Results of Share Purchase Plan
Biochip Advances Towards Clinical-Ready Device Development
Archer Advances Biochip Towards Clinical-Ready Potassium and Lithium Testing Device